Molecular mechanism of SHP2 activation by PD-1 stimulation

M Marasco1, A Berteotti2,3, J Weyershaeuser4,5

  • 1Leibniz University Hannover, Institute of Organic Chemistry and Center for Biomolecular Drug Research, Schneiderberg 38, 30167 Hannover, Germany.

Science Advances
|February 18, 2020
PubMed

Insights

The programmed death-1 (PD-1) pathway

Area of Science:

  • Immunology
  • Structural Biology
  • Biochemistry

Background:

  • The programmed death-1 (PD-1) pathway is crucial in cancer immune escape by suppressing T cell responses.
  • PD-1 activation involves phosphorylation of ITIM and ITSM motifs, leading to SHP2 phosphatase recruitment and T cell inactivation.
  • The precise structural basis and functional roles of PD-1's SH2 domains and phosphorylated motifs in SHP2 activation were previously unknown.

Purpose of the Study:

  • To elucidate the structural mechanism of PD-1-mediated SHP2 activation.
  • To provide functional evidence for the roles of PD-1's phosphorylated motifs and SHP2 domains in T cell inactivation.

Main Methods:

  • X-ray crystallography to determine the structure of the SHP2-PD-1 complex.
  • Biochemical assays to assess SHP2 binding affinities and phosphatase activity.
  • Mutagenesis studies to investigate the functional importance of specific PD-1 motifs and SHP2 domains.

Main Results:

  • The study reveals the detailed structure of the SHP2-PD-1 complex, explaining how dual phosphorylation of PD-1 activates SHP2.
  • ITSM phosphorylation recruits SHP2 to PD-1 via its C-SH2 domain.
  • ITIM phosphorylation, through N-SH2 domain binding, displaces SHP2 from its catalytic pocket, leading to enzyme activation.

Conclusions:

  • Full SHP2 activation requires simultaneous phosphorylation of both PD-1's ITIM and ITSM motifs.
  • This dual phosphorylation induces a novel inter-domain interface, crucial for SHP2 activation.
  • Understanding this mechanism opens avenues for developing targeted immunotherapies by modulating the PD-1/SHP2 interaction.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
16.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.4K